ADAR1 entraps sinister cellular dsRNAs, thresholding antiviral responses

Area of Science:

• Molecular Biology
• Immunology
• Neuroscience

Background:

• ADAR1 enzyme edits adenosine to inosine in double-stranded RNA (dsRNA).
• This editing prevents aberrant activation of innate immune sensors, like MDA5 and PKR.
• Dysfunctional ADAR1 is linked to Aicardi-Goutières syndrome (AGS) encephalopathy.

Purpose of the Study:

• Investigate the role of ADAR1's Z-alpha domain in regulating immune responses.
• Determine the impact of Z-alpha domain mutations on dsRNA sensing and encephalopathy.
• Identify the specific features of dsRNA that trigger aberrant immune activation.

Main Methods:

• Utilized Z-alpha domain-mutant mouse models.
• Analyzed MDA5 and PKR activation pathways.
• Examined cellular dsRNA structures and their interaction with immune sensors.

Main Results:

• Adar1 Zα domain-mutant mice exhibit aberrant MDA5 and PKR activation.
• These mice develop severe encephalopathies, mirroring AGS symptoms.
• Short Z-RNA patches within cellular dsRNA were identified as critical triggers for aberrant antiviral responses.

Conclusions:

• ADAR1's Z-alpha domain is essential for preventing self-inflicted immune activation by cellular dsRNA.
• Aberrant immune responses and encephalopathy result from impaired ADAR1 editing of specific dsRNA structures.
• Understanding ADAR1's editing function provides insights into AGS pathogenesis and potential therapeutic strategies.